Suchergebnisse - "Bonovas, Stefanos"

PubPharm (10)

1

Author's Reply : ``Use of biologics for the management of Crohn's disease''

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Bonovas, S. | Macaluso, F. | Piovani, D. | +3

CommentOn: Dig Liver Dis. 2023 Jul;55(7):989. - PMID 37193630

2

Use of biologics for the management of Crohn's disease : IG-IBD technical review based on the GRADE methodology

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Bonovas, S. | Piovani, D. | Pansieri, C. | +6

3

Use of biologics for the management of Crohn's disease : IG-IBD clinical guidelines based on the GRADE methodology

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Macaluso, F. | Papi, C. | Orlando, A. | +55

CommentIn: Dig Liver Dis. 2023 Jul;55(7):989. - PMID 37193630

4

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis : IG-IBD technical review based on the GRADE methodology

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2022

von Bonovas, S. | Pansieri, C. | Piovani, D. | +6

5

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis : IG-IBD clinical guidelines based on the GRADE methodology

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2022

von Macaluso, F. | Orlando, A. | Papi, C. | +55

6

Long-term safety of approved biologics for ulcerative colitis

enthalten in: Expert opinion on drug safety | 2020

von D'Amico, F. | Parigi, T. | Bonovas, S. | +2

7

Systematic review with meta-analysis : biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Piovani, D. | Danese, S. | Peyrin-Biroulet, L. | +2

8

Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD : an historical perspective

enthalten in: Expert opinion on biological therapy | 2020

von Allen, P. | Bonovas, S. | Danese, S. | +1

9

Clinical development of biologicals and biosimilars - safety concerns

enthalten in: Expert review of clinical pharmacology | 2017

von Bonovas, S. | Peyrin-Biroulet, L. | Danese, S.

10

In the Presence of Conceptual Heterogeneity, Results of Network Meta-analysis Comparing Therapies in Crohn's Disease Need to Be Interpreted With Caution

enthalten in: Gastroenterology | 2015

von Bonovas, S. | Moja, L. | Danese, S.

CommentOn: Gastroenterology. 2015 Feb;148(2):344-54.e5; quiz e14-5. - PMID 25448924

1
[1]